Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
clinical trials
eli lilly
fda
life sciences
national
2
×
national blog main
national top stories
new york blog main
2
×
abbvie
abeona therapeutics
achaogen
affordable care act
allergan
alnylam pharmaceuticals
alzheimer's
astrazeneca
biohaven
biosimilar
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brexanolone
celiac disease
cgpr
chris collins
coherus biosciences
cydan development
deals
detroit blog main
detroit top stories
egfr
europe blog main
foamix pharmaceuticals
gene therapy
gop
indiana blog main
indiana top stories
What
wins
2
×
adults
allergan
alzheimer’s
approved
bio
class
congress
democrats
divided
elections
fallout
fda
losses
medicines
midterm
migraine
monday
new
nod
panel
pill
plenty
political
postpartum
roundup
search
stake
terms
took
treat
treatment
ubrelvy
ubrogepant
week’s
Language
unset
Current search:
national
×
amgen
×
" new york blog main "
×
wins
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel